Biotherapeutics News for June 2010

Results of research on aurora kinase inhibitors announced

BICOLL GmbH and EMBL have announced the successful completion of a joint research project on the identification of active compounds as inhibitors of aurora kinases.
23 June, 2010

World’s first prescription cannabis medicine launched

The UK launch of Sativex®, GW Pharmaceuticals’ oromucosal spray for the treatment of spasticity caused by multiple sclerosis, has been announced.
21 June, 2010

Insulin resistance and glucose intolerance biomarker identified in non-diabetics

Research identifying a novel, early biomarker for insulin resistance and glucose intolerance in a non-diabetic population has now been published.
17 June, 2010

Biotherapeutics News Archive

Results of research on aurora kinase inhibitors announced Results of research on aurora kinase inhibitors announced

World’s first prescription cannabis medicine launched World’s first prescription cannabis medicine launched

Insulin resistance and glucose intolerance biomarker identified in non-diabetics Insulin resistance and glucose intolerance biomarker identified in non-diabetics

Results of research on aurora kinase inhibitors announced

World’s first prescription cannabis medicine launched

Insulin resistance and glucose intolerance biomarker identified in non-diabetics